Aspira Women's Health Inc.
AWH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $9 | $9 | $8 | $7 |
| % Growth | 0.3% | 11.9% | 20.1% | – |
| Cost of Goods Sold | $4 | $4 | $4 | $4 |
| Gross Profit | $5 | $5 | $4 | $3 |
| % Margin | 59.7% | 57.5% | 52.8% | 45% |
| R&D Expenses | $3 | $4 | $6 | $5 |
| G&A Expenses | $10 | $12 | $16 | $13 |
| SG&A Expenses | $18 | $20 | $31 | $30 |
| Sales & Mktg Exp. | $8 | $8 | $15 | $17 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $22 | $24 | $37 | $36 |
| Operating Income | -$16 | -$19 | -$31 | -$33 |
| % Margin | -177.3% | -205.9% | -380.5% | -478.5% |
| Other Income/Exp. Net | $3 | $2 | $1 | $1 |
| Pre-Tax Income | -$13 | -$17 | -$30 | -$32 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$13 | -$17 | -$30 | -$32 |
| % Margin | -142.6% | -182.3% | -365.2% | -465.5% |
| EPS | -0.93 | -1.81 | -3.85 | -4.28 |
| % Growth | 48.6% | 53% | 10% | – |
| EPS Diluted | -0.93 | -1.81 | -3.85 | -4.28 |
| Weighted Avg Shares Out | 14 | 9 | 8 | 7 |
| Weighted Avg Shares Out Dil | 14 | 9 | 8 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | -$0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$16 | -$16 | -$31 | -$32 |
| % Margin | -176.3% | -180.2% | -377.2% | -474.1% |